of OKY-046, a selective inhibitor of thromboxane (TX)A2 syn thetase and a platelet aggregation inhibitor, on in vitro and in vivo models of cerebral vasospasm were studied.
It is well known that cerebral vasospasm followed by aneurysmal rupture and sub arachnoid hemorrhage (SAH) is a significant cause of mortality and morbidity in humans. However, the basic pathogenesis of vasospasm still remains obscure. Recently, important roles of platelets and vascular endothelium in cerebrovascular diseases have been recognized, and several studies have suggested that arachidonic acid metabolites may play an important role in the patho physiology of those disorders (1) (2) (3) (4) (5) (6) (7) (8) . It has been also reported that thromboxane (TX)A2, released mainly from platelets, induces platelet aggregation and has a strong vasoconstrictive effect on cerebral arteries (1, 5, 9) .
More recently, (E)-3-[p-(1 H imidazol 1 ylmethyl)phenyl] 2 propenoic acid (OKY-046), as shown in Fig. 1 , was reported to be a potent and selective inhibitor of TXA2 synthetase, and it was found to inhibit platelet aggregation and TXA2 generation in platelets (10). In this study, we investigated the effect of OKY-046 on cerebral vasospasm models in vitro by an exposure to whole blood from rabbits and observed the effect on in vivo models by an intracranial injection of autologous blood in dogs.
Materials and Methods
In vitro cerebral vasospasm model Rabbits weighing 3.0 to 4.0 kg were sacrificed by a rapid exsanguination via the common carotid artery. After removal of the brain, the basilar artery was dissected free and cut spirally under an operating micro scope. The vessel was mounted at a load of 0.5 g in a 50-ml bath filled with the Tyrode's solution and aerated with 95% 02 and 5% CO2 at 37'C. The vessel was tested for a viability by replacing the Tyrode's solution with the high potassium (140 mM) solution.
The spiral cut basilar artery in a 50-ml bath was exposed to whole blood, which was drawn from the auricular artery of non treated conscious rabbits with one-tenth volume of 3.8% of sodium citrate, in the presence of 0.05 or 0.1 units/ml of thrombin (Sigma, St. Louis, U.S.A.). The contraction was isometrically recorded using a force displacement transducer (Model SB-IT, Nihon Kohden, Tokyo) and observed for 60 min. When whole blood plus thrombin was repeatedly added to the 50-ml bath, no satisfactory reproducibility of the response could be obtained. Therefore, we did not perform the evaluation of test drugs in the same preparation. To examine the effect of drugs on contraction of the basilar artery, each drug was applied to the 50-ml bath 5 min before an addition of whole blood plus thrombin. For ex vivo drug application, whole blood was obtained from conscious rabbits before drug application, at 10 min after an intravenous injection of 10 mg/kg of drug, or at 30 or 120 min during a continuous infusion of 100 ,ag/kg/min of OKY-046, 1 mg/kg/min of OKY-046, or 1 mg/kg/min of ticlopidine.
When ex vivo whole blood treated with a continuous infusion of 1 mg/ kg/min of OKY-046 was used, the level of TXB2 in the 50-ml bath was measured by the radioimmunoassay (RIA) method (11 Angiograms were obtained before and after the autologous blood injection. The caliber of the basilar artery was measured at a point about 1 .0 cm distant from the circle of Willis.
3) Measurement of regional cerebral blood flow (rCBF): The rCBF in normal and autologous blood infused-dogs was determined by a hydrogen clearance tech nique. One platinum electrode (M.T. Giken, Chofu, Japan), 0.3 mm in diameter, was inserted through a drill hole into the gyrus sygmoideus in the frontal lobe, 5 mm in length, and then the drill hole was filled with a dental cement. The H2 clearance curve was recorded with a pH2 monitor apparatus (PHG300, M.T. Giken).
4) Measurement of TXB2 and 6-keto prostaglandin (PG)Fia: Two ml of CSF in dogs was obtained through a needle inserted in the cisterna magna from the foramen magnum before and 3 hr after an intracisteral injection of autologous blood. The concen trations of TXB2 and 6-keto-PGFia in CSF were measured by RIA (11). 5) Drug administration: Test drugs were transorbitally administered at the same time as an injection of autologous blood into the cisterna magna.
Isolated thoracic aorta
The thoracic aorta of rabbits and guinea pigs was isolated and cut spirally. The preparation was mounted at a load of 1 g in the Krebs' solution and aerated with 95% 02 and 5% C02 at 37'C. Test drugs were applied to the aorta 5 min before the addition of vasoactive agonists (norepinephrine, KCI, and PGE1). The response was isometrically measured using a force-displacement transducer (Model SB-IT, Nihon Kohden).
Test drugs
The following drugs were used: OKY-046 (used as sodium, Kissei and Ono, Japan), indomethacin (Sigma, St. Louis, U.S.A.), aspirin (Sanko, Tokyo, Japan), ticlopidine hydrochloride (synthesized in Kissei), verapamil hydrochloride (Knoll, Ludwig shafen, West Germany), cinanserin (syn thesized in Kissei), norepinephrine (Sankyo, Tokyo, Japan) and PGE1 (Sigma). These drugs were dissolved in physiological saline, 0.2 M tris buffer (pH 8.0) or 99.5% ethanol and then diluted to the desired concentration by physiological saline. to the rabbit basilar artery in a 50-ml bath resulted in a rapid contraction, reaching a maximum response of 77% in 5 min. This contraction was persistent, with a gradual decrease to approximately 60% at 60 min. A slight contraction of the vessel by thrombin alone continued over a 60-min observation period. When whole blood alone was added, the contraction was gradually produced, reaching a maximum of 43% at 30 min and sustained over a 60-min period. The contraction by whole blood plus thrombin was significantly inhibited by 10-6 2) Ex vivo drug application:
The results obtained using ex vivo whole blood treated with OKY-046 or ticlopidine are shown in Table 1 . The contraction induced by whole blood from the rabbit with an intravenous injection of 10 mg/kg or an infusion of 100 /cg/kg/min of OKY-046 and 1 mg/kg/ min of ticlopidine did not significantly reduce the contraction before drug application over a 60-min observation period. However, when whole blood of rabbits infused for 30 and 120 min with 1 mg/kg/min of OKY-046 was used, a significant or moderate decrease in the contraction was observed. Table  2  indicates the concentration of TXB2 at 5 min after the addition of whole blood treated with OKY-046.
The concentration of TXB2 was significantly lower than the level before drug application. In vivo cerebral vasospasm model 1) Caliber of the basilar artery: Figure 6 indicates the eftect of OKY-046 and other drugs on the caliber of the basilar artery in autologous blood infused-dogs.
Severe and sustained cerebral vasospasm was anglo graphically observed by an injection of autologous arterial blood into the cisterna magna of dogs. The caliber is expressed as a percentage of the value before the injection of autologous arterial blood. The caliber of the basilar artery was 81% at 45 min, 88% at 90 min, 70% at 6 hr and 82% at 24 hr after the injection of autologous arterial blood. A transorbital injection of 0.005 !tg of OKY-046 into the cisterna magna with autologous arterial blood did not significantly reduce the contraction. However, when 0.05 and 0.5 itg of OKY-046 were used, the vasospasm was significantly inhibited for 6 hr; in particular, the inhibition was marked up to 3 hr. However, at 24 hr, the effect of OKY-046 was not clear. During the same period, no change in systemic arterial blood pressure by an injection of the drug was observed (data not shown). Although an injection of 0.5 iig of indomethacin or 5 ,ug of ticlopidine into the cisterna magna did not affect the vasospasm (data not shown), 5 itg of indomethacin inhibited the vasospasm during 24 hr; The level of inhibition was significant at 0.75 hr and from 3 to 24 hr. The basilar artery of dogs was not contracted by the sham operation, rather a relaxation was observed at 1.5 and 3 hr (data not shown).
2) rCBF: Figure 7 indicates the effect of OKY-046 on the rCBF in autologous blood infused-dogs.
The rCBF is expressed as a percentage of the value before an injection of autologous arterial blood. The time course in changes of the rCBF was similar to that of the caliber of vessel in dogs. The transorbital injection of OKY-046 into the cisterna magna markedly blocked the decrease in the rCBF at a dose of 0.5 fig but not at 0.05 ,ug for 6 hr. Indomethacin at 5.0 icg improved the rCBF. However, the rCBF in non-treated dogs was not influenced by an intravenous injection of 3 and 30 mg/kg of OKY-046 (Table 3) .
3) Levels of TXB2 and 6-keto-PGF1a in CSF: As shown in Fig. 8 , the levels of TXB2 and 6-keto-PGF1a in CSF increased 4.4 and 3.3 times more than those before an injection of autologous arterial blood, respectively. An injection of 0.5 iig of O KY-046 into the cisterna magna markedly prevented an increase in TXB2 and slightly increased the level of 6-keto-PGF,a.
Thus, the ratio of 6 keto-PGF,a/TXB2 is changed from 1.7 to 1.2 in control dogs and from 1.5 to 5.2 in OKY 046-treated dogs. Isolated thoracic aorta OKY-046 at 10-6 to 10-3 M had no ap parent effect on the basal tone (data not shown) or on the dose-response curves of various agonists (norepinephrine, KCI and PGE1) in the isolated spiral thoracic aorta of rabbits and/or guinea pigs (Fig. 9) . by blood clotting, it has been suggested that platelets may have a role in the production of cerebral artery constriction (6) (7) (8) . Early studies suggested that platelets might liberate various spasmogens, especially serotonin (12). Recently, participation of vasoactive prostaglandins (specifically TXA2) has been observed in several investigations (1, 7, 9) . Thus, we studied the effects of OKY 046, which inhibits TXA2 generation and platelet aggregation (10), on experimental cerebral vasospasm in vitro and in vivo.
As the contraction of the isolated basilar artery of rabbits caused by whole blood and thrombin was markedly suppressed by verapamil, the contraction seems to be produced by extracellular Ca, but not by mechanical factors such as an adhesion of the basilar artery to the brim of the 50-m1 organ bath or to the stick holder of the preparation. However, when thrombin alone was added to the 50-m1 bath, a significant vasocontraction was not produced. The con traction of the basilar artery by whole blood plus thrombin was moderately inhibited by the addition of OKY-046 and/or cinanserin and indomethacin alone into the 50-m1 bath. Therefore, it is likely that the contraction may be induced by TXA2, other vasoactive prostaglandins and serotonin, but not thrombin. When ex vivo whole blood infused with 1 mg/kg/min of OKY-046 in rabbits was used, the cerebral vasospasm was inhibited and the level of T XB2 in the 50-m1 bath markedly diminished. As the 1.0 ml of whole blood was diluted one-fiftieth in the 50-m1 bath, the concentration of OKY-046 sur rounding the basilar artery was considered to be comparable to that in an infusion of 20 /cg/kg/min of OKY-046 in vivo. Thus we think that 1 mg/kg/min of OKY-046 is not too a high dose and that the suppression of cerebral vasospasm by OKY-046 is probably due to the inhibition of TXA2 generation. Similarly, it has been reported that a pro staglandin synthetase or TX synthetase inhibitor blocks vasoconstriction by an exposure to whole blood (6) (7) (8) .
In the experiments on in vivo cerebral vasospasm in dogs, to examine the direct effects of drugs, each drug was administered into the cisterna magna. OKY-046 at 0.05 and 0.5 iig significantly inhibited the con traction of the basilar artery during 6 hr after an injection of autologous arterial blood, but it did not at 24 hr. On the other hand, indomethacin influenced the late vasocon traction and the early vasocontraction. Therefore, we assume that a mechanism of the early vasocontraction is implicated in the generation of TXA2 and that a late vaso contraction is produced by other vasoactive prostaglandins or that the effect of OKY-046 may be abolished because of the disap pearance of the drug from the cisterna magna. OKY-046 effected an inhibition of the cerebral vasospasm at a lower concentration than that which inhibited the decrease in rCBF of autologous blood infused-dogs, but indomethacin improved both cerebral vasospasm and the decrease in rCBF at the same concentration.
The membrane perme ability of both drugs may be different. Therefore, the following explanation for the differential effect of OKY-046 seems plausible:
the basilar artery in dogs is directly exposed to OKY-046 by an intra cisternal injection of the drug, but insufficient OKY-046 might arrive at the site (the gyrus sygmoideus in the frontal lobe) where the rCBF was measured. On the other hand, we consider that indomethacin might sufficiently permeate into the site where the rCBF was measured.
Prostaglandin metabolism has been reported to be modified in experimental cerebral vasospasm and in patients suffering from SAH and stroke (3, 4, 23) . More recently, the balance of TXA2 and prostacyclin (PG12) has been implicated in the control of the basal tone of cerebral vessels and circu lation (1, 21, 24, 25) . However, the opposite relations such as the increase in TXA2 and decrease in PG12 are not always observed in animals with cerebral vasospasm and in SAH patients (26). Our results that both the levels of TXB2 and 6-keto-PGF1a in CSF increased in dogs did not agree with previous studies that PG12 generation in vessels decreased during the cerebral vasospasm (3, 4) . On the other hand, the ratio of 6-keto-PGF1a/TXB2 in OKY-046-treated dogs clearly increased, because OKY-046 at 0.5 gig markedly sup pressed the increase in TXB2 level and slightly increased 6-keto-PGF1a.
A specific inhibition of TXA2 generation by OKY-046 causes PG endoperoxide accumulation, subsequently it is used for PG12 generation (the so-called steal phenomenon) (27) . Conversely, OKY 046 did not directly affect the vessel response (Fig. 9) . We conclude that the efficacy of OKY-046 against the cerebral vasospasm in the in vitro and in vivo models is due to an inhibition of platelet aggregation (10), an inhibition of TXA2 generation, and an increase in the ratio of PG12/TXA2.
